Literature DB >> 20480546

Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor beta.

Paul A Grimaldi1.   

Abstract

PURPOSE OF REVIEW: This review focuses on the emerging knowledge about peroxisome proliferator-activated receptor beta regulatory functions on metabolism, inflammation, and cellular stress. RECENT
FINDINGS: Recent publications have confirmed the important roles of peroxisome proliferator-activated receptor beta in adaptive metabolic responses of skeletal muscle and have also implicated the nuclear receptor in the regulation of inflammation and oxidative stress in various tissues. The mechanisms implicated in these effects have been partially elucidated.
SUMMARY: Peroxisome proliferator-activated receptors mediate the transcriptional effects of fatty acids and fatty acid derivatives and regulate many physiological functions, including metabolism and development. Use of potent and specific agonists revealed that activation of peroxisome proliferator-activated receptor beta efficiently reverses some metabolic syndrome-associated abnormalities by affecting metabolic, inflammatory, and oxidative stress responses in several tissues through both genomic and nongenomic modes of action.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480546     DOI: 10.1097/mol.0b013e32833884a4

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  17 in total

Review 1.  Skeletal muscle lipid flux: running water carries no poison.

Authors:  Katsuhiko Funai; Clay F Semenkovich
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

Review 2.  Fatty acid transport proteins, implications in physiology and disease.

Authors:  Melissa Kazantzis; Andreas Stahl
Journal:  Biochim Biophys Acta       Date:  2011-09-25

3.  Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.

Authors:  Jennifer E Foreman; Wen-Chi L Chang; Prajakta S Palkar; Bokai Zhu; Michael G Borland; Jennie L Williams; Lance R Kramer; Margie L Clapper; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2011-03-11       Impact factor: 4.784

4.  Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).

Authors:  Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Anne Schönbauer; Wolfgang Meissner; Maren Scharfe; Michael Jarek; Helmut Blöcker; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

5.  Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity.

Authors:  Pei-Li Yao; Jose L Morales; Bokai Zhu; Boo-Hyon Kang; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cancer Ther       Date:  2014-01-24       Impact factor: 6.261

6.  Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation.

Authors:  Donghao Shang; Tie Zheng; Jian Zhang; Ye Tian; Yuting Liu
Journal:  Tumour Biol       Date:  2016-07-22

7.  The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.

Authors:  Baktybek Kojonazarov; Himal Luitel; Akylbek Sydykov; Bhola K Dahal; Mark J Paul-Clark; Sara Bonvini; Anna Reed; Ralph T Schermuly; Jane A Mitchell
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 8.  Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs.

Authors:  H J Dranse; M E M Kelly; B D Hudson
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

9.  PPARbeta activation induces rapid changes of both AMPK subunit expression and AMPK activation in mouse skeletal muscle.

Authors:  E Lendoye; B Sibille; A-S Rousseau; J Murdaca; P A Grimaldi; P Lopez
Journal:  Mol Endocrinol       Date:  2011-07-28

10.  Knockdown of PPAR δ gene promotes the growth of colon cancer and reduces the sensitivity to bevacizumab in nude mice model.

Authors:  Lie Yang; Jin Zhou; Qin Ma; Cun Wang; Keling Chen; Wenjian Meng; Yongyang Yu; Zongguang Zhou; Xiaofeng Sun
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.